Medium-level algorithms with systems focus
Reliability engineers face coding rounds emphasizing distributed systems concepts, monitoring algorithms, and data structures for large-scale operations.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Focus areas that matter most for SRE and platform reliability positions. Explore key insights and preparation tips to help you excel in your interview process.
Reliability engineers face coding rounds emphasizing distributed systems concepts, monitoring algorithms, and data structures for large-scale operations.
Design resilient systems with emphasis on monitoring, alerting, incident response, and failure recovery patterns.
Monitoring
Metrics, logs, and observability systems
Resilience
Circuit breakers and failure handling
Scaling
Auto-scaling and capacity planning
Different companies emphasize various aspects of reliability engineering based on their infrastructure needs and scale.
SLO/SLI design and error budget management
Netflix
Chaos engineering and microservices reliability
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers approximately 65% lower housing costs compared to San Francisco, with median home prices around $200K versus $1.4M+ in the Bay Area. Your Reliability Engineer salary stretches significantly further, enabling homeownership and substantial savings while maintaining proximity to DC's tech corridor.
Baltimore's reliability engineering market remains less saturated than major tech hubs, creating better opportunities for career advancement and competitive offers.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States